<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The objective of the present study was to investigate the effect of leptin on the progression of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> by analyzing the serum leptin concentration and Ob-R gene expression in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> tissues </plain></SENT>
<SENT sid="1" pm="."><plain>Tissue samples were obtained from 31 patients who underwent surgical resection for colon (18 cases) and metastatic colon (13 cases) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Serum leptin concentration was determined by an enzyme-linked immunosorbent assay (ELISA) and Ob-R <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression by real-time polymerase chain reaction (RT-PCR) for both groups </plain></SENT>
<SENT sid="3" pm="."><plain>ELISA data were analyzed by the Student t-test and RT-PCR data were analyzed by the Mann-Whitney U-test </plain></SENT>
<SENT sid="4" pm="."><plain>RT-PCR results demonstrated that <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of Ob-R in human <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> was higher than in local <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues </plain></SENT>
<SENT sid="5" pm="."><plain>On the other hand, mean serum leptin concentration was significantly higher in local <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients compared to patients with <z:e sem="disease" ids="C0948380" disease_type="Neoplastic Process" abbrv="">metastatic colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The results of the present study suggest a role for leptin in the progression of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> to <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> without <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In other words, significantly increased Ob-R <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression and <z:hpo ids='HP_0003292'>decreased serum leptin</z:hpo> concentration in patients with metastatic <z:hpo ids='HP_0003003'>colon cancer</z:hpo> indicate that sensitization to leptin activity may be a major indicator of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> to the colon tissue and the determination of leptin concentration and leptin gene expression may be used to aid the diagnosis </plain></SENT>
</text></document>